Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Conferences

ecancer travels so that you don't have to. Explore the latest conference coverage in global oncology and find out where we are going next.

NCRI 2013

3 - 6 Nov 2013

BT Convention Centre, Liverpool, United Kingdom of Great Britain and Northern Ireland

Variations in terminal sedation practices across the UK, Netherlands and Belgium

Dr Jane Seymour - Nottingham University, UK

Variations in terminal sedation practices across the UK, Netherlands and Belgium ( Dr Jane Seymour - Nottingham University, UK )

Comparing toxicity profiles for 72 hour infusional and conventional bleomycin in testicular cancer

Dr Jonathan Shamash - Barts Cancer Institute, London, UK

Comparing toxicity profiles for 72 hour infusional and conventional bleomycin in testicular cancer ( Dr Jonathan Shamash - Barts Cancer Institute, London, UK )

Polygenic susceptibility: What might it tell us?

Sir Bruce Ponder - University of Cambridge, UK

Polygenic susceptibility: What might it tell us? ( Sir Bruce Ponder - University of Cambridge, UK )

Give early breast tumours fewer, larger doses of radiation, rather than more, smaller doses

Prof John Yarnold - The Royal Marsden, London, UK

Give early breast tumours fewer, larger doses of radiation, rather than more, smaller doses ( Prof John Yarnold - The Royal Marsden, London, UK )

Diet, the microbiome, and colon cancer risk

Dr Stephen O' Keefe - University of Pittsburgh, USA

Diet, the microbiome, and colon cancer risk ( Dr Stephen O' Keefe - University of Pittsburgh, USA )

UK fight for tobacco control

Prof Linda Bauld - University of Stirling, Stirling, UK

UK fight for tobacco control ( Prof Linda Bauld - University of Stirling, Stirling, UK )

Engineering of polymeric nanoparticles for medical applications

Dr Omid Farokhzad - Harvard Medical School, Boston, USA

Engineering of polymeric nanoparticles for medical applications ( Dr Omid Farokhzad - Harvard Medical School, Boston, USA )

DIfferences in prostate treatment between ROI and Northern Ireland, and measuring patient opinions

Dr Anna Gavin - North Ireland Cancer Registry, Queens University, Belfast, UK

DIfferences in prostate treatment between ROI and Northern Ireland, and measuring patient opinions ( Dr Anna Gavin - North Ireland Cancer Registry, Queens University, Belfast, UK )

HPV prevalence in screened population and types associated with cervix disease

Dr Lesley Anderson - Queens University, Belfast, UK

HPV prevalence in screened population and types associated with cervix disease ( Dr Lesley Anderson - Queens University, Belfast, UK )

Treatment decision making, screening and palliative care

Dr Jane Seymour - Nottingham University, UK

Treatment decision making, screening and palliative care ( Dr Jane Seymour - Nottingham University, UK )

Biobanks, rare tumours and the importance of collecting primary material

Dr Andy Hall - Newcastle University, UK

Biobanks, rare tumours and the importance of collecting primary material ( Dr Andy Hall - Newcastle University, UK )

Reduction cancer rates following the introduction of two-view mammography

Amanda Dibden - Queen Mary University London, UK

Reduction cancer rates following the introduction of two-view mammography ( Amanda Dibden - Queen Mary University London, UK )

The DietCompLyf study: Breast cancer survival and phytoestrogen consumption

Dr Ruth Swann - University of Westminster, UK

The DietCompLyf study: Breast cancer survival and phytoestrogen consumption ( Dr Ruth Swann - University of Westminster, UK )

The NCRN Pomi-T study: polyphenol rich whole food supplement slows PSA progression in prostate cancer

Dr Robert Thomas - Cambridge University Hospitals, UK

The NCRN Pomi-T study: polyphenol rich whole food supplement slows PSA progression in prostate cancer ( Dr Robert Thomas - Cambridge University Hospitals, UK )

Molecular imaging using PET-CT and personalised therapy with neuroendocrine tumours

Dr Harshad Kulkarni - Zentralklinik, Bad Berka, Germany

Molecular imaging using PET-CT and personalised therapy with neuroendocrine tumours ( Dr Harshad Kulkarni - Zentralklinik, Bad Berka, Germany )

The aTTom study: randomised comparison of continuing adjuvant in ER positive or ER untested early breast cancer

Dr Daniel Rea - University of Birmingham, UK

The aTTom study: randomised comparison of continuing adjuvant in ER positive or ER untested early breast cancer ( Dr Daniel Rea - University of Birmingham, UK )

The immune microenvironment as an anti-cancer therapeutic strategy

Dr Lisa Coussens - Oregon Science & Health University, USA

The immune microenvironment as an anti-cancer therapeutic strategy ( Dr Lisa Coussens - Oregon Science & Health University, USA )

POSH study: Obesity and the outcome of young breast cancer patients

Dr Ellen Copson - University of Southampton, UK

POSH study: Obesity and the outcome of young breast cancer patients ( Dr Ellen Copson - University of Southampton, UK )

PETROC / OV21: Phase II/III trial of peritoneal treatment for ovarian cancer

Dr Chris Gallagher - Barts and the London NHS Trust, UK

PETROC / OV21: Phase II/III trial of peritoneal treatment for ovarian cancer ( Dr Chris Gallagher - Barts and the London NHS Trust, UK )

Developing trials with surgeons: Hughes Abdominal Repair Trial (HART) Trial

Dr Julie Cornish - University of Cardiff, UK and Dr Andrew Torrace - University of Birmingham, UK

Developing trials with surgeons: Hughes Abdominal Repair Trial (HART) Trial ( Dr Julie Cornish - University of Cardiff, UK and Dr Andrew Torrace - University of Birmingham, UK )

The molecular basis of cancer

Dr Gerard Evan - University of Cambrige, UK

The molecular basis of cancer ( Dr Gerard Evan - University of Cambrige, UK )

Combined use of PET and MRI imaging

Dr Bernd Pichler - University of Tübingen, Germany

Combined use of PET and MRI imaging ( Dr Bernd Pichler - University of Tübingen, Germany )

More from ecancer